Liraglutide
Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
Novo Nordisk · Phase 3 · Completed · Enrollment 56
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Liraglutide | 1 participants | 2 participants | 10 participants | n/r | 0 |
| Placebo | 0 participants | 0 participants | 2 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.